Great-West Lifeco stock at EUR 55.46, target 18.5 percent higher
Published on 10/09/2026 at 20:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Great-West Lifeco stock was EUR 55.46 at Lang & Schwarz on October 9, 2026, up 1.02 percent from EUR 54.90.
- The Toronto-listed share traded at CAD 88.51, with a P/E ratio of 18.25 and a market capitalization of CAD 79.2 billion.
- The consensus price target was CAD 104.91, 18.53 percent above the CAD 88.51 quote.
- Great-West Lifeco is scheduled to report third-quarter 2026 results on November 4, 2026.
Great-West Lifeco stock was trading at EUR 55.46 at Lang & Schwarz on October 9, 2026 at 8:34 p.m. CEST, up 1.02 percent versus the prior close of EUR 54.90. The move places the German-market quote above its previous close while the Toronto listing provides the valuation context for the company.
Price and daily range
The TSX quote was CAD 88.51 on October 9, 2026, up CAD 0.96 or 1.10 percent from CAD 87.55. Trading volume was 155,076 shares against an average of 1,116,504, giving the session a lighter turnover profile than the recent average.
Great-West Lifeco's 52-week range on the TSX was CAD 57.56 to CAD 95.96. The CAD 88.51 price stood 7.76 percent below the 52-week high, while the year-low comparison leaves the share 53.77 percent above its low.
Valuation and analyst target
The Toronto-listed company had a market capitalization of CAD 79.2 billion and a trailing P/E ratio of 18.25 on October 9, 2026. Its dividend yield was 3.00 percent, adding an income measure to the valuation picture.
Business Insider reported on October 8, 2026 that Barclays maintained a Hold rating and a CAD 91.00 target. The same report cited a consensus target of CAD 104.91, which is 18.53 percent above the CAD 88.51 TSX price.
Comparison with peers
Great-West Lifeco: plus 1.02 percent, P/E 18.25, market capitalization CAD 79.2 billion
Sun Life Financial (USD): plus 0.51 percent, P/E 18.62, market capitalization USD 42.7 billion
Manulife Financial (USD): plus 0.81 percent, P/E 16.37, market capitalization USD 70.9 billion
Next reporting date
TradingView lists November 4, 2026 as the next earnings date for the third quarter of 2026. The date gives the valuation figures a defined upcoming reporting marker, while the current price remains the clearest daily market signal.
Business scale
Great-West Lifeco operates through Canada Life, Empower and Irish Life across Canada, the United States and Europe. The company website lists more than CAD 4.6 billion in base earnings, CAD 3.3 trillion in total client assets and 40 million customer relationships as of December 31, 2025.
Trading remains above the low
The latest Lang & Schwarz quote was EUR 55.46 on October 9, 2026 at 8:34 p.m. CEST, compared with a prior close of EUR 54.90. The further course of trading is shown by the continuously updated real-time quote of Great-West Lifeco stock.
Great-West Lifeco stock facts
- Company: Great-West Lifeco Inc.
- ISIN: CA39138C1068
- Ticker: GWO
- Primary exchange: Toronto Stock Exchange
- Price Lang & Schwarz (as of October 9, 2026, 8:34 p.m. CEST): EUR 55.46
- Change versus prior close: plus 1.02 percent
- Prior close Lang & Schwarz (October 8, 2026): EUR 54.90
- Market capitalization: CAD 79.2 billion (as of October 9, 2026)
- 52-week range: CAD 57.56-CAD 95.96 (as of October 9, 2026)
- Sector / Industry: Financial Services / Insurance - Life
- Next earnings date: November 4, 2026
Market context: Market report S&P TSX Composite.

